The following technology assessments were released by the National Institute for Health and Care Excellence (NICE) in second two weeks of August 2017:
Medtech Innovation Briefings for Biopatch (a hydrophilic foam dressing impregnated with chlorhexidine gluconate (CHG), and is used for covering central venous or arterial catheter sites), Urethrotech UCD (a device designed to be used for difficult or failed catheterisations in men), VEST external stent for coronary artery bypass grafts (a kink-resistant external stent for saphenous vein grafts used during coronary artery bypass graft surgery).
MedTech Innovation Briefing is the NICE's advice program for innovative technologies. It provides an overview of clinical effectiveness, safety, and cost. It does not offer a formal guidance and it, therefore, does not provide any recommendations.
Subscribe to our newsletter delivered every second week not to miss important reimbursement information.